Cargando…

Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis

Detalles Bibliográficos
Autores principales: Jarius, Sven, Haas, Jürgen, Wildemann, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971044/
https://www.ncbi.nlm.nih.gov/pubmed/36333454
http://dx.doi.org/10.1007/s00415-022-11417-z
_version_ 1784898025725886464
author Jarius, Sven
Haas, Jürgen
Wildemann, Brigitte
author_facet Jarius, Sven
Haas, Jürgen
Wildemann, Brigitte
author_sort Jarius, Sven
collection PubMed
description
format Online
Article
Text
id pubmed-9971044
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99710442023-03-01 Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis Jarius, Sven Haas, Jürgen Wildemann, Brigitte J Neurol Letter to the Editors Springer Berlin Heidelberg 2022-11-04 2023 /pmc/articles/PMC9971044/ /pubmed/36333454 http://dx.doi.org/10.1007/s00415-022-11417-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editors
Jarius, Sven
Haas, Jürgen
Wildemann, Brigitte
Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
title Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
title_full Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
title_fullStr Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
title_full_unstemmed Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
title_short Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis
title_sort rho gtpase-activating protein 17 (arhgap17) as additional autoimmune target in arhgap26-igg/anti-ca autoantibody-associated autoimmune encephalitis
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971044/
https://www.ncbi.nlm.nih.gov/pubmed/36333454
http://dx.doi.org/10.1007/s00415-022-11417-z
work_keys_str_mv AT jariussven rhogtpaseactivatingprotein17arhgap17asadditionalautoimmunetargetinarhgap26igganticaautoantibodyassociatedautoimmuneencephalitis
AT haasjurgen rhogtpaseactivatingprotein17arhgap17asadditionalautoimmunetargetinarhgap26igganticaautoantibodyassociatedautoimmuneencephalitis
AT wildemannbrigitte rhogtpaseactivatingprotein17arhgap17asadditionalautoimmunetargetinarhgap26igganticaautoantibodyassociatedautoimmuneencephalitis